Cumberland Pharmaceuticals Inc.
$3.15
▲
2.26%
2026-04-21 06:11:01
www.cumberlandpharma.com
NMS: CPIX
Explore Cumberland Pharmaceuticals Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$47.57 M
Current Price
$3.15
52W High / Low
$6.27 / $1.85
Stock P/E
—
Book Value
$1.66
Dividend Yield
—
ROCE
-6.97%
ROE
-12.17%
Face Value
—
EPS
$-0.19
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
93
Beta
-0.33
Debt / Equity
41.48
Current Ratio
1.01
Quick Ratio
0.84
Forward P/E
22.07
Price / Sales
1.04
Enterprise Value
$44.62 M
EV / EBITDA
32.97
EV / Revenue
1
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | PRF Technologies Ltd. | $2.64 | — | $2.31 M | — | -53.59% | -90.37% | $17.95 / $1.8 | $10.29 |
| 2. | BioAge Labs, Inc. | $18.8 | — | $820.58 M | — | -33.77% | -27.09% | $24 / $3.63 | $7.28 |
| 3. | Lantheus Holdings, Inc. | $83.97 | 23.41 | $5.47 B | — | 16.66% | 21.45% | $108.91 / $47.25 | $16.87 |
| 4. | Sonoma Pharmaceuticals, Inc. | $2.65 | — | $4.59 M | — | -38.66% | -81.18% | $6.92 / $2 | $1.98 |
| 5. | Ironwood Pharmaceuticals, Inc. | $4.42 | 29.94 | $719.09 M | — | 76.78% | -8.53% | $5.78 / $0.53 | $-1.61 |
| 6. | Cardiol Therapeutics Inc. | $1.51 | — | $230.46 M | — | -162.05% | -1.59% | $2.17 / $1.23 | $0.08 |
| 7. | Regencell Bioscience Holdings Limited | $29.09 | — | $13.89 B | — | -57.45% | -54.81% | $83.6 / $0.7 | $0.01 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 13.68 M | 8.29 M | 10.84 M | 11.71 M | 10.44 M | — |
| Operating Profit | -1.37 M | -1.97 M | -0.75 M | 1.29 M | -1.84 M | — |
| Net Profit | -1.41 M | -1.94 M | -0.74 M | 1.26 M | -1.9 M | — |
| EPS in Rs | -0.09 | -0.13 | -0.05 | 0.08 | -0.13 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 44.52 M | 37.87 M | 39.55 M | 42.01 M |
| Operating Profit | -2.79 M | -6.43 M | -9.55 M | -5.7 M |
| Net Profit | -2.84 M | -6.48 M | -6.28 M | -5.57 M |
| EPS in Rs | -0.19 | -0.43 | -0.42 | -0.37 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 76.82 M | 75.58 M | 81.78 M | 92.93 M |
| Total Liabilities | 52.28 M | 53.04 M | 52.52 M | 56.95 M |
| Equity | 24.88 M | 22.85 M | 29.6 M | 36.27 M |
| Current Assets | 37.06 M | 36.45 M | 35.71 M | 45.87 M |
| Current Liabilities | 36.74 M | 31.62 M | 27.98 M | 28.58 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 4.93 M | -0.61 M | 6.09 M | 8.45 M |
| Investing CF | -4.71 M | 0.06 M | -0.11 M | -13.67 M |
| Financing CF | -6.75 M | 0.2 M | -7.42 M | -2.06 M |
| Free CF | 4.75 M | -0.79 M | 5.64 M | 6.38 M |
| Capex | -0.18 M | -0.18 M | -0.45 M | -2.07 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -4.26% | -5.85% | — | — |
| Earnings Growth % | -3.19% | -12.73% | — | — |
| Profit Margin % | -17.11% | -15.88% | -13.26% | — |
| Operating Margin % | -16.99% | -24.16% | -13.58% | — |
| Gross Margin % | 82.61% | 84.66% | 78.29% | — |
| EBITDA Margin % | 0.48% | 6.28% | 0.79% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.